QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Sym004 Versus TAS-102 in Patients With mCRC
- Status
- WITHDRAWN
- Phase
- PHASE3
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
- Status
- TERMINATED
- Phase
- PHASE3
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trifluridin/tipirACil in MeTastatIc Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Immunophenotyping of Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options
- Status
- COMPLETED
- Phase
- NA
FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
- Status
- COMPLETED
- Phase
- PHASE4
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
- Status
- TERMINATED
- Phase
- PHASE2
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1